Abcellera-discovered antibody, bebtelovimab, receives u.s. fda emergency use authorization for the treatment of mild-to-moderate covid-19

Vancouver, british columbia--(business wire)---- $abcl #abcellera--abcellera-discovered antibody, bebtelovimab, receives u.s. fda emergency use authorization for the treatment of mild to moderate covid-19
ABCL Ratings Summary
ABCL Quant Ranking